175 related articles for article (PubMed ID: 32662748)
1. Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study.
Hidalgo de la Cruz M; Valsasina P; Gobbi C; Gallo A; Zecca C; Bisecco A; Tedeschi G; Filippi M; Rocca MA
Mult Scler; 2021 May; 27(6):827-840. PubMed ID: 32662748
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal patterns of cortical thinning in multiple sclerosis.
Tsagkas C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Magon S
Hum Brain Mapp; 2020 Jun; 41(8):2198-2215. PubMed ID: 32067281
[TBL] [Abstract][Full Text] [Related]
3. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
[TBL] [Abstract][Full Text] [Related]
4. Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
Valsasina P; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Yiannakas M; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Filippi M; Rocca MA;
Mult Scler; 2022 May; 28(6):885-899. PubMed ID: 34605323
[TBL] [Abstract][Full Text] [Related]
5. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
[TBL] [Abstract][Full Text] [Related]
6. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Tillema JM; Hulst HE; Rocca MA; Vrenken H; Steenwijk MD; Damjanovic D; Enzinger C; Ropele S; Tedeschi G; Gallo A; Ciccarelli O; Rovira A; Montalban X; de Stefano N; Stromillo ML; Filippi M; Barkhof F;
Mult Scler; 2016 Jun; 22(7):901-9. PubMed ID: 26432859
[TBL] [Abstract][Full Text] [Related]
7. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
[TBL] [Abstract][Full Text] [Related]
8. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
[TBL] [Abstract][Full Text] [Related]
9. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
10. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
[TBL] [Abstract][Full Text] [Related]
11. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
12. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Filippi M;
Neurology; 2021 Mar; 96(11):e1561-e1573. PubMed ID: 33441452
[TBL] [Abstract][Full Text] [Related]
13. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
14. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
Fujimori J; Fujihara K; Wattjes M; Nakashima I
Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
[TBL] [Abstract][Full Text] [Related]
15. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
16. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
[TBL] [Abstract][Full Text] [Related]
17. Cortical surface thickness, subcortical volumes and disability between races in relapsing-remitting multiple sclerosis.
Bross M; Hackett M; Bernitsas MM; Bao F; Carla-Santiago-Martinez ; Bernitsas E
Mult Scler Relat Disord; 2021 Aug; 53():103025. PubMed ID: 34052742
[TBL] [Abstract][Full Text] [Related]
18. The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI.
Treaba CA; Herranz E; Barletta VT; Mehndiratta A; Ouellette R; Sloane JA; Klawiter EC; Kinkel RP; Mainero C
J Neurol; 2021 Jul; 268(7):2473-2481. PubMed ID: 33523256
[TBL] [Abstract][Full Text] [Related]
19. Cortical atrophy is relevant in multiple sclerosis at clinical onset.
Calabrese M; Atzori M; Bernardi V; Morra A; Romualdi C; Rinaldi L; McAuliffe MJ; Barachino L; Perini P; Fischl B; Battistin L; Gallo P
J Neurol; 2007 Sep; 254(9):1212-20. PubMed ID: 17361339
[TBL] [Abstract][Full Text] [Related]
20. Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis.
Eijlers AJC; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Pouwels PJW; Uitdehaag BMJ; Barkhof F; Vrenken H; Schoonheim MM; Geurts JJG
Neurology; 2019 Oct; 93(14):e1348-e1359. PubMed ID: 31484713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]